Our International Scientific Advisory Board

The Monash Biomedicine Discovery Institute (BDI) International Scientific Advisory Board (ISAB) provides strategic counsel to the Monash BDI Executive Committee, to further develop a high-level picture of our future research strategy and the plans needed to position us as a world-leading research institute.

The ISAB held its inaugural meeting from Wednesday 1 May to Friday 3 May, 2019 at Monash University in Melbourne, Australia.

Key focus areas:

a)  pursuing discovery research excellence

b)  building and leveraging clinical and industry partnerships

c)  emerging opportunities and new developments

d)  areas of weakness to address

e)  international partnerships

f)  delivering against strategic aims

g)  maximising resources and opportunities locally, nationally and internationally


The Monash BDI ISAB Members

Professor Warwick Anderson

Secretary-General, International Human Frontier Science Program Organization

Professor Amander Clark

Chair, Department of Molecular Cell and Developmental Biology, University of California Los Angeles, USA

Professor Dame Anna F. Dominiczak

Regius Professor of Medicine, Vice Principal and Head of College of Medical, Veterinary and Life Sciences, University of Glasgow, UK

Professor Jeff Errington

Director of the Centre for Bacterial Cell Biology (CBCB), Newcastle University, UK

Professor Iain W. Mattaj

Director, Human Technopole, Italy

Former Director General, EMBL, Germany

Professor Valerie O’Donnell

Director, Division of Infection and Immunity, Cardiff University, UK

Professor Bruce W. Stillman

President/CEO, Cold Spring Harbor Laboratory, USA

Professor Rachel Wong

Professor of Biological Structure, University of Washington, USA

Professor Juleen Zierath

Karolinska Institutet, Sweden